Tuesday, July 5, 2005

OncoLink coverage of the World Conference on Lung Cancer

OncoLink coverage of the 11th Annual Meeting of the World Conference on Lung Cancer from July 3-6, 2005 in Barcelona, Spain. OncoLink reporters provide in-depth, up-to-the-minute coverage of sessions and presentations.

A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941) Presenter: J. van MeerbeeckPresenter's Affiliation: University Hospital, Ghent, BelgiumType of Session: PlenaryBackground There remains significant controversy in the optimal treatment of patients with locally advanced stage IIIA NSCLC with...
ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I-III) non small cell lung cancer (NSCLC) patients (pts) Presenter: R. RosellPresenter's Affiliation: Catalan Institute of Oncology, Badalona, SpainType of Session: PlenaryBackground Recent studies have shown a significant improvement in overall survival with the addition of adjuvant chemotherapy after...
ISEL: A Phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC, in patients with advanced non-small cell lung cancer (NSCLC) who had received one or two prior chemotherapy regimens Presenter: N. ThatcherPresenter's Affiliation: Christie Hospital, Manchester, UKType of Session: PlenaryBackground Gefitinib (IRESSA) is an oral medication that acts as a small molecule inhibitor of EGFR. There have been two Phase II trials...
Lung cancer patient utilization of an Internet based cancer clinical trials matching system Dr. James M Metz, MD, Editor-in-Chief of OncoLink, presenting research at the WCLC titled Lung cancer patient utilization of an Internet based cancer clinical trials matching system. ...
Patient initiation of complementary and alternative medical therapies (CAM) during conventional lung cancer treatment Dr. James M Metz, MD, Editor-in-Chief of OncoLink, presenting research at the WCLC poster presentation session titled Patient initiation of complementary and alternative medical...
Percutaneous radiofrequency ablation of primary NSCLC Presenter: M. AmbrogiPresenter's Affiliation: Cardiac and Thoracic Department, Pisa, ItalyType of Session: PlenaryBackground Radiofrequency ablation (RFA) causes local destruction of tumors after insertion of electrodes attached to an RF...
Potential differences between lung cancer patients using the Internet and patients in the clinic Maggie Hampshire, RN, BSN, OCN, Managing Editor of OncoLink, displaying research at the WCLC poster presentation session titled Potential differences between lung cancer patients using...